1. Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis. Issue 5 (May 2017) Authors: Shankar-Hari, Manu; Fear, David; Lavender, Paul; Mare, Tracey; Beale, Richard; Swanson, Chad; Singer, Mervyn; Spencer, Jo Journal: Critical care medicine Issue: Volume 45:Issue 5(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design of a Bayesian adaptive phase 2 proof‐of‐concept trial for BAN2401, a putative disease‐modifying monoclonal antibody for the treatment of Alzheimer's disease. Issue 1 (4th February 2016) Authors: Satlin, Andrew; Wang, Jinping; Logovinsky, Veronika; Berry, Scott; Swanson, Chad; Dhadda, Shobha; Berry, Donald A. Journal: Alzheimer's & dementia Issue: Volume 2:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O4–05–01: A first‐in‐human study of BAN2401, a novel monoclonal antibody against beta‐amyloid protofibrils. (1st July 2013) Authors: Lai, Robert; Logovinsky, Veronika; Kaplow, June M.; Gu, Kenan; Yu, Yanke; Möller, Christer; Navia, Bradford; Swanson, Chad; Lannfelt, Lars; Satlin, Andrew Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 17 Page Start: P689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P4‐181: INITIAL LEARNINGS FROM SCREENING STRATEGIES IN THE BAN 2401‐G000‐201 TRIAL: AN EARLY ALZHEIMER'S DISEASE STUDY. (1st July 2014) Authors: Logovinsky, Veronika; Swanson, Chad; Lai, Robert; Do, Ira; Kaplow, June M.; Rabe, Martin P.; Gordon, Robert; Wang, Jinping; Xu, Lu; Basun, Hans; Lannfelt, Lars; Satlin, Andrew Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 23 Page Start: P855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P4‐310: Composite measures in Alzheimer's disease clinical trials: How an in‐study data quality program ensures immediate and ongoing quality of the sum of their parts. (1st July 2015) Authors: Miller, David; Swanson, Chad; Logovinsky, Veronika; Hernandez, Antonio; Bellitz, Samantha Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 19 Page Start: P903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4–281: Microglial involvement and amyloid reduction with BAN2401/mAb158, a monoclonal antibody with high selectivity for protofibrils: In vitro and ex vivo analyses. (1st July 2013) Authors: Kaplow, June M.; Kusnetov, Galina; Mastroeni, Diego; Navia, Bradford; Kumar, Namita; Biscaro, Barbara; Koyama, Akhiko; Möller, Christer; Lai, Robert; Swanson, Chad; Logovinsky, Veronika; Lannfelt, Lars; Satlin, Andrew; Rogers, Joseph Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P807 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P4–282: A multimodal imaging study of mAb158, a murine monoclonal antibody with high selectivity for amyloid protofibrils, in Tg2576 mice. (1st July 2013) Authors: Navia, Bradford; Perdomo, Carlos; Krause, Stephen; Kaplow, June M.; Koyama, Akihiko; Teceno, Tyler; Gershman, Ben; Logovinsky, Veronika; Swanson, Chad; Lai, Robert; Möller, Christer; Lannfelt, Lars; Satlin, Andrew; McCracken, Paul Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P4–286: Pharmacology of BAN2401: A monoclonal antibody selective for beta‐amyloid protofibrils. (1st July 2013) Authors: Swanson, Chad; Kaplow, June M.; Mastroeni, Diego; Rogers, Joseph; Waara, Erik Rollman; Navia, Bradford; Lai, Robert; Logovinsky, Veronika; Möller, Christer; Lannfelt, Lars; Satlin, Andrew Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Population pharmacokinetic‐pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease. (27th September 2022) Authors: Hayato, Seiichi; Takenaka, Osamu; Sreerama Reddy, Sree Harsha; Landry, Ishani; Reyderman, Larisa; Koyama, Akihiko; Swanson, Chad; Yasuda, Sanae; Hussein, Ziad Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 12(2022) Page Start: 1578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and tolerability of BAN2401 - a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody. Issue 1 (December 2016) Authors: Logovinsky, Veronika; Satlin, Andrew; Lai, Robert; Swanson, Chad; Kaplow, June; Osswald, Gunilla; Basun, Hans; Lannfelt, Lars Journal: Alzheimer's research & therapy Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗